Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations
Year: 2017
Type: article
Study design: Observational Study
Source: Journal of Cystic Fibrosis
Institutions: University of Wisconsin–Madison, University of Alabama at Birmingham, UAB Medicine, Seattle Children's Research Institute, Johns Hopkins University, University of Arizona, University of Washington, Case Western Reserve University, University of Pittsburgh, National Jewish Health, Cystic Fibrosis Foundation, Medical University of South Carolina
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Medical University of South Carolina, University of Wisconsin-Madison, University of Washington, Johns Hopkins University, Case Western Reserve University, University of South Carolina, Seattle Children's Research Institute, National Jewish Health, National Institutes of Health, South Carolina Clinical and Translational Research Institute, Medical University of South Carolina, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, Children's Hospital of Pittsburgh
Awards: G1263966483, G1545474459, G1619017181, G2169531248, G2529322290, G2817389857, G308544354, G3801776485, G3991547501, G4000357393, G4134382261, G4655598527, G5781166989, G5847104900, G5966924457, Institutional Clinical and Translational Science Award, G6563963068, G6867887761, G7284302963, G8388727300, G8637150146, G884562342, G9000037373, G9000177589, G9000268964, Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era
OpenAlex ID: W2608524918